Abstract
Particle irradiation of cancerous disease has gained great traction in recent years. The ability for particle therapy centers to deliver radiation with a highly conformal dose distribution while maintaining minimal exit or excess dose delivered to normal tissue, coupled with various biological advantages particularly found with heavy-ion beams, enables treatment of diseases inapproachable with conventional radiotherapy. Here, we present a review of the current status of particle therapy with regard to cancers of the gastrointestinal tract, including esophagus, liver, pancreas, and recurrent rectal cancer.
| Original language | English |
|---|---|
| Article number | 17 |
| Journal | Current Oncology Reports |
| Volume | 18 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Jan 1 2016 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Oncology
Cite this
Particle radiation therapy for gastrointestinal cancers. / Shinoto, Makoto; Ebner, Daniel K.; Yamada, Shigeru.
In: Current Oncology Reports, Vol. 18, No. 3, 17, 01.01.2016.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Particle radiation therapy for gastrointestinal cancers
AU - Shinoto, Makoto
AU - Ebner, Daniel K.
AU - Yamada, Shigeru
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Particle irradiation of cancerous disease has gained great traction in recent years. The ability for particle therapy centers to deliver radiation with a highly conformal dose distribution while maintaining minimal exit or excess dose delivered to normal tissue, coupled with various biological advantages particularly found with heavy-ion beams, enables treatment of diseases inapproachable with conventional radiotherapy. Here, we present a review of the current status of particle therapy with regard to cancers of the gastrointestinal tract, including esophagus, liver, pancreas, and recurrent rectal cancer.
AB - Particle irradiation of cancerous disease has gained great traction in recent years. The ability for particle therapy centers to deliver radiation with a highly conformal dose distribution while maintaining minimal exit or excess dose delivered to normal tissue, coupled with various biological advantages particularly found with heavy-ion beams, enables treatment of diseases inapproachable with conventional radiotherapy. Here, we present a review of the current status of particle therapy with regard to cancers of the gastrointestinal tract, including esophagus, liver, pancreas, and recurrent rectal cancer.
UR - http://www.scopus.com/inward/record.url?scp=85008511993&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85008511993&partnerID=8YFLogxK
U2 - 10.1007/s11912-016-0499-8
DO - 10.1007/s11912-016-0499-8
M3 - Article
C2 - 26849660
AN - SCOPUS:85008511993
VL - 18
JO - Current Oncology Reports
JF - Current Oncology Reports
SN - 1523-3790
IS - 3
M1 - 17
ER -